Skip to content
Review Open access

NMR Metabolomics in Veterinary Medicine: From Biomarker Discovery to Clinical Implementation

Sep 2026 · Veterinary Sciences · Vol 13 · 0 citations · 127 references
Medicine

TL;DR

This review examines whether nuclear magnetic resonance, a laboratory method that measures many small chemicals in blood, urine, milk and other samples, could improve disease detection and monitoring in veterinary medicine.

Abstract

Simple Summary Animal diseases can be difficult to detect early, and many current tests provide limited information about how a disease is affecting the whole body. This review examines whether nuclear magnetic resonance, a laboratory method that measures many small chemicals in blood, urine, milk and other samples, could improve disease detection and monitoring in veterinary medicine. Published studies have found chemical patterns associated with cancer, infections, respiratory and digestive disorders, kidney disease, hormonal conditions and joint disease in several animal species. However, most studies involved relatively small groups of animals, and their findings have rarely been confirmed in separate populations. Smaller and easier-to-use instruments, together with computer-assisted analysis, may make this approach more accessible, but routine use will require larger studies conducted at several centres, standard procedures, comparison with existing tests and evidence that it is affordable and improves veterinary decisions. If these requirements are met, this technology could support earlier diagnosis, better treatment selection, reduced unnecessary antimicrobial use, improved animal welfare and lower economic losses in livestock production.

Read PDF

Similar papers

Review Open access Sep 2026

Proteomics in Gastrointestinal Diseases of Companion Animals: Current State and Knowledge Gaps

Simple Summary Studying protein profiles is useful for investigating disease mechanisms and searching for biological markers. These biological markers can be used to diagnose diseases, monitor and predict treatment responses. This review provides an overview of the methods used to study proteins, outlines the process o...

Jane Yu, C. Ruaux · 0 citations
Open access Sep 2026

Metabonomics and it’s Potential Application in Clinic Diagnosis and Therapy

Metabolomics is a new-generation omics technology emerging after genomics, transcriptomics, and proteomics, It focuses on all small-molecule metabolites with molecular weights below 1 kDa within biological systems, providing a direct reflection of the terminal phenotypic changes in the physiological and pathological st...

Chun-Lei Xie, Cong-Cong Tang, Qi Tang et al. · 0 citations
Open access Sep 2026

Urinary Volatilomic Profiling Reveals Candidate Metabolomic Signatures Associated with Colorectal Cancer

Interestingly, one person originally classified as healthy was later diagnosed with advanced colorectal cancer, and their urine pattern had already resembled that of cancer patients before this diagnosis was known, suggesting that urine testing might one day help detect colorectal cancer earlier, in a simple and non-in...

Francisca Viveiros, P. Berenguer, I. Jardim et al. · 0 citations
Review Open access Aug 2026

Clinical metabolomics: analytical workflows, data interpretation, and translational considerations

Clinical metabolomics has emerged as a powerful systems biology approach for characterizing metabolic alterations associated with human health and disease. By comprehensively profiling endogenous metabolites in clinical biospecimens, clinical metabolomics provides valuable insights into disease mechanisms, biomarker di...

Wonwoong Lee, Shaheed Ur Rehman, Jin Ah Won et al. · 0 citations
Review Open access Sep 2026

What's next for metabolomics?

Metabolomics has become a mainstream approach that examines the metabolic composition of biological systems in relation to their physiological and disease states. Using analytical techniques such as nuclear magnetic resonance spectroscopy and mass spectrometry, metabolomics enables detailed profiling of small molecules...

N. Reisdorph, Corey D. Broeckling, R. Brüschweiler et al. · 1 citation
Open access Aug 2026

NMR metabolomics and glycomics for cancer detection in patients with non-specific symptoms: a prospective observational cohort study

These findings validate the SCAN1 metabolomic signature in a more clinically complex cohort and indicate that integrating glycomics with metabolomics provides complementary biological information for cancer discrimination.

T. Kacerova, A. Yates, J. Larkin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.